@misc{angelova_protein_entrapment_2013, 
author={Angelova, A.,Angelov, B.,Drechsler, M.,Haramus, V.M.,Lesieur, S.},
title={Protein entrapment in PEGylated lipid nanoparticles},
year={2013},
howpublished = {journal article},
doi = {https://doi.org/10.1016/j.ijpharm.2013.06.006},
abstract = {Defining appropriate delivery strategies of therapeutic proteins, based on lipid nanoparticulate carriers, requires knowledge of the nanoscale organization that determines the loading and release properties of the nanostructured particles. Nanoencapsulation of three cationic proteins (human brain-derived neurotrophic factor (BDNF), α-chymotrypsinogen A, and histone H3) was investigated using anionic nanoparticle (NP) carriers. PEGylated lipid NPs were prepared from self-assembled liquid crystalline phases involving monoolein and eicosapentaenoic acid. Inclusion of the antioxidant α-tocopherol favoured the preparation of stealth hexosome carriers. The purpose of the present work is to reveal the structural features of the protein-loaded lipid nanocarriers by means of high resolution small-angle X-ray scattering (SAXS) and cryogenic transmission electron microscopy (cryo-TEM). The obtained results indicate that protein entrapment is concentration-dependent and may significantly modify the inner liquid crystalline structure of the lipid nanocarriers through changes in the interfacial curvature and hydration.},
note = {Online available at: \url{https://doi.org/10.1016/j.ijpharm.2013.06.006} (DOI). Angelova, A.; Angelov, B.; Drechsler, M.; Haramus, V.; Lesieur, S.: Protein entrapment in PEGylated lipid nanoparticles. International Journal of Pharmaceutics. 2013. vol. 454, no. 2, 625-632. DOI: 10.1016/j.ijpharm.2013.06.006}}